[Schizophrenia and drug abuse: genetic aspects].
Poirier
M F
MF
SHU Hôpital Sainte-Anne, 1, rue Cabanis, 75014 Paris.
D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics; D002986:Clinical Trials as Topic; D005787:Gene Frequency; D006801:Humans; D002189:Marijuana Abuse / Q000150:complications; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D050637:Receptors, Dopamine D3; D012559:Schizophrenia / Q000209:etiology* / Q000235:genetics / Q000503:physiopathology; D012565:Schizophrenic Psychology; D019966:Substance-Related Disorders / Q000150:complications*
D019208:Brain-Derived Neurotrophic Factor; C493593:DRD3 protein, human; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3